Rising Investment in the Pharmaceutical Sector Propelling the Indian Drug Discovery Informatics Market

Published: Mar 2021

Indian drug discovery informatics market is projected to grow at a significant CAGR during the forecast period (2020-2026). The rising investment in pharmaceutical R&D in the country encourages the demand for drug discovery informatics solutions among various contract research organizations and pharmaceutical companies. The companies in the country including Dr. Reddy’s Labs, Wockhardt, Advinus, Lupin, Cipla, Zydus Cadila, and many others have started investing in the R&D of small molecules with a novel mechanism of action. Drug Controller General of India (DCGI) is the regulatory body encouraging local Indian pharma companies to go deeper into innovation and development that is further projected to provide significant scope for the market.

Browse the full report description Indian Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), by End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/indian-drug-discovery-informatics-market

As per the India Brand Equity Foundation, the pharmaceutical R&D industry of India was valued at $26.1 billion in genetics in 2016 and the market is expected to be $55 billion by 2020. Around 304 Abbreviated New Drug Application (ANDA) approvals were received by India in 2017 from the US Food and Drug Administration (USFDA). The country accounts for around 30% by volume and nearly 10% by value in a $70-$80 billion US generics industry. Therefore, rising drug discovery related R&D in the country is projected to contribute considerably to the growth of the drug discovery informatics market in the near future. 

Market Coverage

Report Elements

Details

Study Period

2019-2026

Base year

2019

Forecast period

2020-2026

Segments Covered

By Function and by End-User

Key Companies Profiled

Accenture PLC, Eurofins GSC Lux SARL, Jubilant Life Science, Novo Informatics Pvt. Ltd., Infosys Ltd., and others

Key questions addressed by the report

  • What is the market growth rate during the forecast period?
  • Which segment dominates the market in the base year?
  • Which segment will project the fastest growth in the market during the forecast period?
  • How COVID-19 will impact the market growth in 2020 and the coming years?

o Recovery Timeline

o Deviation from the pre-COVID-19 forecast

o Most affected segment

o Recommendations 

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Indian Drug Discovery Informatics Market – Segmentation

By Function

  • Docking
  • Molecular Modeling
  • Libraries and Database Preparation
  • Sequencing and Target Data Analysis
  • Others

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organization (CRO)
  • Others (Research Institutes) 

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/indian-drug-discovery-informatics-market